Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Joins Others in Clearing Ranbaxy Drugs As Safe

This article was originally published in PharmAsia News

Executive Summary

Australia's drug authority has joined other nations and international groups in declaring drugs made by Ranbaxy Laboratories safe for their markets.

Australia's drug authority has joined other nations and international groups in declaring drugs made by Ranbaxy Laboratories safe for their markets. The Therapeutics Goods Administration issued a statement saying it had no evidence any Ranbaxy products in Australia pose a danger to patients. The TGA was part of an international inspection team whose recommendation led to World Health Organization conclusions Ranbaxy had turned the corner on its problems with producing drugs. The Aussie agency also conducted its own tests of products from the India drug maker. (Click here for more)

"Ranbaxy Drugs Safe, Says Australian Drug Regulator" - Economic Times (India) (7/3/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC085016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel